Benzinga··Vandana SinghNatera's Signatera Test Offers Path to Surgery-Free Breast Cancer Treatment
Natera's MRD test shows older breast cancer patients may avoid surgery. Study demonstrates perfect detection rates, boosting NTRA stock 5.26% to $196.68.
NTRAbreast cancerSignatera